Barinthus Biotherapeutics plc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Barinthus Biotherapeutics plc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2025.
  • Barinthus Biotherapeutics plc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $3.32M, a 54.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $3.32M -$3.96M -54.4% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $3.86M -$3.55M -48% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $4.38M -$3.2M -42.2% Dec 31, 2024 10-Q 2025-08-07
Q3 2024 $7.44M -$30K -0.4% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $7.29M -$421K -5.46% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.41M -$315K -4.08% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $7.58M -$172K -2.22% Dec 31, 2023 10-K 2025-03-20
Q3 2023 $7.47M -$84K -1.11% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.71M -$632K -7.58% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $7.72M +$1.02M +15.3% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $7.75M +$496K +6.84% Dec 31, 2022 10-K 2024-03-20
Q3 2022 $7.56M -$1.22M -13.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $8.34M +$6.3M +309% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.7M +$4.6M +219% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $7.26M +$5.12M +240% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $8.78M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.04M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.1M Mar 31, 2021 10-Q 2021-06-14
Q4 2020 $2.14M Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.